José María Miró Meda-rekin lankidetzan egindako argitalpenak (5)

2021

  1. Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy

    Biochemical Pharmacology, Vol. 192

2018

  1. Evaluation of resistance to HIV-1 infection ex vivo of PBMCs isolated from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors

    Biochemical Pharmacology, Vol. 156, pp. 248-264

2017

  1. Potential role of tyrosine kinase inhibitors during primary HIV-1 infection

    Expert Review of Anti-Infective Therapy

  2. Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection

    Expert Opinion on Drug Safety, Vol. 16, Núm. 5, pp. 547-559

2016

  1. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells

    Biochemical Pharmacology, Vol. 106, pp. 30-45